Avanos Medical Inc (NYSE:AVNS)
$ 15.2 -0.2 (-1.3%) Market Cap: 698.55 Mil Enterprise Value: 811.75 Mil PE Ratio: 44.71 PB Ratio: 0.57 GF Score: 63/100

Q2 2019 Avanos Medical Inc Earnings Call Transcript

Aug 06, 2019 / 01:00PM GMT
Release Date Price: $37.23 (-1.82%)
Operator

Good day, and welcome to the Avanos Second Quarter Earnings Conference Call and Webcast. (Operator Instructions) Please note this event is being recorded.

I will now like to turn the conference over to Mr. Dave Crawford, Vice President, Investor Relations. Mr. Crawford, the floor is yours sir.

David Crawford
Avanos Medical, Inc. - VP of FP&A and IR and Treasurer

Good morning, everyone, and thanks for joining us. It's my pleasure to welcome you to the Avanos Second Quarter Earnings Conference Call. With me this morning is Joe Woody, CEO. Joe will provide an overview of our performance, priorities and transformation. Then I will review our second quarter results and offer details on our financial performance and outlook for 2019. We'll finish the call with Q&A. A presentation for today's call is available on the Investors section of our website, avanos.com.

As a reminder, our comments today contain forward-looking statements related to the company, our expected performance, economic conditions and our industry. No assurance can be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot